A clinical trial is the scientific term for the step-by-step process that studies or tests in humans a new procedure, drug, vaccine or device for prevention, treatment, screening or quality of life. The majority of clinical trials conducted in the United States test new drugs
- Prevention trials look at drugs, vaccines or lifestyle changes that may help prevent disease.
- Diagnostic trials look at ways of detecting or finding out more about a disease.
- Treatment trials may monitor new drugs or evaluate new combinations of established treatments.
- Screening trials may be conducted to find out if a screening test (such as for prostate cancer) is useful in detecting the disease at an early stage and, as a result, reduce the number of deaths from the disease.
- Quality of Life trials may study the psychological impact of the disease and ways to improve a person's comfort and quality of life.
Clinical Trials.govClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine. Explore 359,518 research studies in all 50 states and in 219 countries. Parents and others can find federally funded research programs by consulting this NIH Web site.
Before participating in a study, talk to your health care provider and learn about the risks and potential benefits.
NBCI Clinical Approach to HED
The National Black Church Initiative (NBCI) will conduct itself with the highest ethical standards in advocating clinical trials participation by our faith based communities. The mission of NBCI clinical program is to increase the representation of African Americans in clinical trials. It is imperative that African Americans participate in clinical trials to assure that our population receives the benefits of cutting edge drug therapy and modern medical practice.
This is a major pillar in our efforts to deal with issues of health disparities. NBCI seeks to assure our faith base communities of the value, benefits, protections and trustworthiness of the clinical trials for which it advocates and encourages participation. In doing so, NBCI itself must be assured of the protections and the appropriateness of the protocols and the processes. Therefore, we have adopted a set of core principles that will govern our decisions regarding involvement in any clinical trial:
- Ongoing inform consent process including signature of properly constructed document by all trial participants or their legally authorized representative;
- Proper review and approval by a duly constituted and certified Institutional Review Board;
- Accessibility of resource for answering all participants' questions in a culturally and linguistically appropriate manner;
- An appropriate period for patient deliberation on the decision to participate;
- Culturally and linguistically appropriate literature, video, and web based education modules concerning the trial when these tools are used.